Kores
Incorporated in 1936, Kores is among India’s most trusted and respected brands. As a highly diversified business conglomerate, Kores India Ltd. operates across multiple industry verticals. From office products to pharmaceuticals, foundry to engineering infrastructure and business automation products to textiles, our company is renowned for offerings that deliver high value.
What Began in 1981 as a ‘specialty chemicals’ initiative is today Kores’ Pharmaceuticals & Chemicals business. Since then, the business has evolved to become a recognised manufacturer of high grade active pharmaceutical ingredients (APIs) and pharmaceutical online intermediates (PIs).
Driven by robust manufacturing processes and stringent quality norms, the Pharmaceuticals & Chemicals business produces Theophylline and its advanced derivatives, mucolytic expectorants, anti-diabetes and cardiovascular drugs, and key intermediates for anti-Cancer and anti-Parkinson’s drugs at our cGMP manufacturing facility at Roha.
Our focus on innovation has enabled our highly qualified team of researchers to leverage the latest technologies and develop a wide range of products in our state-of-the-art laboratory at Pawane, Navi Mumbai. Kores Pharmaceuticals & Chemicals team has helped clients across the world to discover greater efficiency and value through our products and high-end services such as customer research and synthesis.
Kores Pharmaceuticals has emerged as a leader in the domestic market, especially in the therapeutic categories such as bronchodilators and mucolytic expectorant with its consistency, reliability and competitiveness. Many Xanthine derivatives have been developed for European customers. The division also manufactures niche pharmaceutical intermediates for anti-Cancer, anti-Diabetes and anti-Parkinson’s drugs.
Show all images
Local time: 
Follow us:
Number of products:
